StockData
Ardelyx, Inc. logo

Ardelyx, Inc. (ARDX) stock

ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3059% below fair value
$3.09−0.03 (-0.96%)

Close on Nov 13, 2026Market cap $769.99MP/E –Yield –

Ardelyx total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Ardelyx's total debt was $26.54M at Sep 30, 2022. For fiscal 2021 it was $32.26M.

Annual total debt

PeriodPeriod endValueChange
FY2021Dec 31, 2021$32.26M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2022Sep 30, 2022$26.54M–
Q2 FY2022Jun 30, 2022$26.37M–
Q1 FY2022Mar 31, 2022$26.14M–
Q4 FY2021Dec 31, 2021$32.26M–

More Ardelyx figures

See a number that looks wrong?